Who is sponsoring NCT05071872?

NCT05071872 is sponsored by Straub Medical AG.

What drugs are being tested in NCT05071872?

Interventions in NCT05071872: Atherectomy/Thrombectomy.

What condition does NCT05071872 study?

NCT05071872 studies Arteriovenous Graft Thrombosis.

Is NCT05071872 still recruiting?

NCT05071872 is currently completed. Last updated 9 February 2023.

Last reviewed 2023-02-09 · How we verify

NCT05071872

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Completed Last updated 9 February 2023

What this trial tests

trial testing Atherectomy/Thrombectomy in Arteriovenous Graft Thrombosis in 127 participants. Completed in 8 June 2022.

Timeline

6 October 2021

Primary endpoint
8 June 2022

8 June 2022

Quick facts

Lead sponsor	Straub Medical AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	127
Start date	6 October 2021
Primary completion	8 June 2022
Estimated completion	8 June 2022
Sites	1 location across Czechia

Drugs / interventions tested

Atherectomy/Thrombectomy

Conditions studied

Arteriovenous Graft Thrombosis — all drugs for Arteriovenous Graft Thrombosis →

Sponsor

Straub Medical AG

Who can join

18 and older, any sex, with Arteriovenous Graft Thrombosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective Post-Market Clinical Follow Up of Rotarex®S \& Aspirex®S Catheters in treating thrombotic occlusion of Arteriovenous Graft for dialysis access (Artificial Bypass)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Atherectomy/Thrombectomy

Trials testing the same drug.

NCT04010123 — Post-Market Clinical Follow Up of Rotarex®S Catheter · completed

Other Straub Medical AG trials

Trials by the same sponsor.

NCT04010123 — Post-Market Clinical Follow Up of Rotarex®S Catheter · completed
NCT03116750 — Post-Market Clinical Follow-up Study with ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05071872 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Straub Medical AG
Last refreshed: 9 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05071872.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing